Tag: Phosphoinositide 3-kinase inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Phosphoinositide 3-kinase inhibitor

AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in ...

Added to Collection on: 2021-04-10 18:33:45

Tags for this article:

Drugs
Health sciences
Life Sciences
Antineoplastic drugs
Breakthrough therapy
Orphan drugs
Specialty drugs
Drug discovery
Phosphoinositide 3-kinase inhibitor
Verastem Oncology
Duvelisib
Umbralisib
Scott Fields

Click the tags to see associated articles and topics

View Article Details
Year in Review: Follicular Lymphoma | MedPage Today

Added to Collection on: 2023-12-01 22:28:34

Tags for this article:

Lymphoma
Non-Hodgkin lymphoma
Orphan drugs
Antineoplastic drugs
Phosphoinositide 3-kinase inhibitor
Targeted therapy
Copanlisib
Diffuse large B-cell lymphoma
Rituximab
Hodgkin lymphoma
Ibritumomab tiuxetan
P110α

Click the tags to see associated articles and topics

View Article Details
Roche's inavolisib combination reduces the risk of disease progression by 57% in ... - Yahoo Finance

Added to Collection on: 2023-12-08 22:22:09

Tags for this article:

Amides
Specialty drugs
Aminopyridines
Breakthrough therapy
Protein kinase inhibitors
Palbociclib
Phosphoinositide 3-kinase inhibitor
Alpelisib
Fulvestrant
Breast cancer
Triple-negative breast cancer
PI3K/AKT/mTOR pathway
F. Hoffmann-La Roche
San Antonio
Roche Group

Click the tags to see associated articles and topics

View Article Details
Inavolisib Plus Palbociclib and Fulvestrant Improves PFS in PIK3CA-Mutated HR+ Breast Cancer

Added to Collection on: 2023-12-08 18:14:54

Tags for this article:

Aminopyridines
Protein kinase inhibitors
Breakthrough therapy
Amides
Palbociclib
Fulvestrant
Genentech
Breast cancer
HER2
Inavolisib
Buparlisib
Phosphoinositide 3-kinase inhibitor

Click the tags to see associated articles and topics

View Article Details
FDA Grants Breakthrough Therapy Designation to Inavolisib for PIK3CA-Mutated Breast Cancer

Added to Collection on: 2024-05-21 20:36:23

Tags for this article:

Amides
Aminopyridines
Antineoplastic drugs
Specialty drugs
Cyclopentanes
Inavolisib
Phosphoinositide 3-kinase inhibitor
Palbociclib
Alpelisib
Breast cancer
Fulvestrant
P110α

Click the tags to see associated articles and topics

View Article Details
Tafasitamab Plus Lenalidomide/Rituximab Improves PFS in Relapsed/Refractory Follicular ...

Added to Collection on: 2024-12-10 22:48:23

Tags for this article:

Orphan drugs
Non-Hodgkin lymphoma
Lymphoma
Antineoplastic drugs
Rituximab
Tafasitamab
Lenalidomide
Marginal zone lymphoma
Selinexor
Phosphoinositide 3-kinase inhibitor
Laurie H. Sehn

Click the tags to see associated articles and topics

View Article Details
New Data Show Genentech's Itovebi Significantly Extended Survival in a Certain Type of HR ...

Added to Collection on: 2025-05-31 18:38:52

Tags for this article:

Cyclopentanes
Lactams
Protein kinase inhibitors
Selective estrogen receptor degraders
Antineoplastic drugs
Palbociclib
Fulvestrant
Inavolisib
Breast cancer
P110α
Alpelisib
Phosphoinositide 3-kinase inhibitor
Genentech
Itovebi
Roche Group

Click the tags to see associated articles and topics

View Article Details
New data show Roche's Itovebi significantly extended survival in - GuruFocus

Added to Collection on: 2025-05-31 12:25:33

Tags for this article:

Cyclopentanes
Lactams
Protein kinase inhibitors
Antineoplastic drugs
Palbociclib
Breast cancer
Inavolisib
P110α
Fulvestrant
HER2
Phosphoinositide 3-kinase inhibitor
Alpelisib

Click the tags to see associated articles and topics

View Article Details
New data show Roche's Itovebi significantly extended survival in a certain type of HR ...

Added to Collection on: 2025-06-01 00:38:31

Tags for this article:

Breast cancer
Antineoplastic drugs
Phosphoinositide 3-kinase inhibitor
Targeted therapy
Inavolisib
P110α
Phosphoinositide 3-kinase
HER2
Metastatic breast cancer
PI3K/AKT/mTOR pathway
Alpelisib
United States
Itovebi
Fulvestrant

Click the tags to see associated articles and topics

View Article Details
Follicular Lymphoma Pipeline Insight 2025: Next-Gen Anti-CD20 - openPR.com

Added to Collection on: 2025-08-05 22:10:06

Tags for this article:

Orphan drugs
Non-Hodgkin lymphoma
Antineoplastic drugs
Benzamides
Phosphoinositide 3-kinase inhibitor
Targeted therapy
Genmab
Diffuse large B-cell lymphoma
Lymphoma
Rituximab
Odronextamab
Obinutuzumab

Click the tags to see associated articles and topics

View Article Details
Book a Demo